In a new working paper, Preparing for a Pandemic: Accelerating Vaccine Availability, economists from seven research institutions, the World Bank, and the UK’s foreign Commonwealth and Development Office make the economic case for accelerating the arrival and distribution of COVID-19 vaccines, and they offer a roadmap to get it done. Nobel Laureate Michael Kremer of UChicago and Susan Athey of Stanford Business share key findings of this research, including opportunities to enhance the speed of acquiring and administering vaccines. They also address the economics of advance contracts, the value of making further investments in vaccine capacity now, and the benefits of a vaccine exchange to facilitate the best use of existing doses around the world.